Ligand Pharmac-B
LGND288.0102.79% ( -8.270 )
Ligand Pharmac-B (LGND)
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole,...
- Open
- 294.630
- High
- 298.285
- Low
- 287.190
- Prev. Close
- 296.280
- Volume
- 356.72K
- Turnover
- 103.67M
- Avg Price
- 290.622
- Bid/Ask Ratio
- --
- Amplitude
- 3.74%
- 52wk High
- 326.630
- Volume Ratio
- 1.29
- Turnover Ratio
- 1.85%
Ligand Pharmac-B Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$323.3012.25%
Forecast & RatingStrong buy
9analysts
- Strong buy77.78%
- Buy22.22%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 23 at 06:00 AM
Ligand Pharmaceuticals to report Q2 2026 results, host conference call
- Tip Ranks · Jul 22 at 04:56 AM
Bank of America Securities Reaffirms Their Buy Rating on Ligand Pharma (LGND)
- Market Beat · Jul 15 at 11:12 AM
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $340.00 at Royal Bank Of Canada
- PUBT · Jul 14 at 08:01 AM
Ligand closes acquisition of XOMA Royalty for $39 per share cash
- Market Beat · Jul 13 at 07:35 AM
3 Overlooked Stocks Positioned for the Next Market Rotation
- Market Beat · Jul 8 at 08:42 AM
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $332.00 at Stifel Nicolaus
